Search
Descriptor English: Lipoproteins, HDL
Descriptor Spanish: Lipoproteínas HDL
Descriptor Portuguese: Lipoproteínas HDL
Descriptor French: Lipoprotéines HDL
Entry term(s): Density Lipoprotein, High
HDL Lipoproteins
Heavy Lipoproteins
High Density Lipoprotein
High Density Lipoproteins
High-Density Lipoprotein
High-Density Lipoproteins
Lipoprotein, High Density
Lipoprotein, High-Density
Lipoproteins, Heavy
Lipoproteins, High-Density
alpha Lipoprotein
alpha Lipoproteins
alpha-1 Lipoprotein
alpha-Lipoprotein
alpha-Lipoproteins
Tree number(s): D10.532.432
D12.776.521.479
RDF Unique Identifier: https://id.nlm.nih.gov/mesh/D008075
Scope note: A class of lipoproteins of small size (4-13 nm) and dense (greater than 1.063 g/ml) particles. HDL lipoproteins, synthesized in the liver without a lipid core, accumulate cholesterol esters from peripheral tissues and transport them to the liver for re-utilization or elimination from the body (the reverse cholesterol transport). Their major protein component is APOLIPOPROTEIN A-I. HDL also shuttle APOLIPOPROTEINS C and APOLIPOPROTEINS E to and from triglyceride-rich lipoproteins during their catabolism. HDL plasma level has been inversely correlated with the risk of cardiovascular diseases.
Annotation: hyperalphalipoproteinemia = LIPOPROTEINS, HDL /blood (IM) + HYPERLIPOPROTEINEMIAS (IM); hypoalphalipoproteinemia = LIPOPROTEINS, HDL /blood (IM) + HYPOLIPOPROTEINEMIAS (IM); familial hypoalphalipoproteinemia = TANGIER DISEASE; /defic: consider also HYPOLIPOPROTEINEMIAS
Allowable Qualifiers: AD administration & dosage
AE adverse effects
AG agonists
AI antagonists & inhibitors
AN analysis
BI biosynthesis
BL blood
CF cerebrospinal fluid
CH chemistry
CL classification
CS chemical synthesis
DE drug effects
DF deficiency
EC economics
GE genetics
HI history
IM immunology
IP isolation & purification
ME metabolism
PD pharmacology
PH physiology
PK pharmacokinetics
PO poisoning
RE radiation effects
SD supply & distribution
ST standards
TO toxicity
TU therapeutic use
UL ultrastructure
UR urine
Previous Indexing: Lipoproteins (1966-1971)
Public MeSH Note: 74
History Note: 74(72)
Related: Tangier Disease MeSH
DeCS ID: 8249
Unique ID: D008075
Documents indexed in the Virtual Health Library (VHL): Click here to access the VHL documents
Date Established: 1974/01/01
Date of Entry: 1999/01/01
Revision Date: 2020/05/27
Lipoproteins, HDL - Preferred
Concept UI M0012584
Scope note A class of lipoproteins of small size (4-13 nm) and dense (greater than 1.063 g/ml) particles. HDL lipoproteins, synthesized in the liver without a lipid core, accumulate cholesterol esters from peripheral tissues and transport them to the liver for re-utilization or elimination from the body (the reverse cholesterol transport). Their major protein component is APOLIPOPROTEIN A-I. HDL also shuttle APOLIPOPROTEINS C and APOLIPOPROTEINS E to and from triglyceride-rich lipoproteins during their catabolism. HDL plasma level has been inversely correlated with the risk of cardiovascular diseases.
Preferred term Lipoproteins, HDL
Entry term(s) Density Lipoprotein, High
HDL Lipoproteins
Heavy Lipoproteins
High Density Lipoprotein
High Density Lipoproteins
High-Density Lipoprotein
High-Density Lipoproteins
Lipoprotein, High Density
Lipoprotein, High-Density
Lipoproteins, Heavy
Lipoproteins, High-Density
alpha Lipoprotein
alpha Lipoproteins
alpha-Lipoprotein
alpha-Lipoproteins
alpha-1 Lipoprotein - Narrower
Concept UI M0012582
Preferred term alpha-1 Lipoprotein



We want your feedback on the new DeCS / MeSH website

We invite you to complete a survey that will take no more than 3 minutes.


Go to survey